Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Acrivon Therapeutics, Inc. insider trades

Acrivon Therapeutics, Inc.'s insiders made 0 buys and 17 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Nov 17, 2026Blume-Jensen PeterSale1,276US$1.45Form 4
Nov 17, 2026Blume-Jensen PeterSale504US$1.45Form 4
Nov 17, 2026Devroe EricSale628US$1.45Form 4
Nov 17, 2026Gamelin ErickSale416US$1.45Form 4
Nov 17, 2026Miller MarySale193US$1.45Form 4
Nov 17, 2026Peterson KatharineSale107US$1.45Form 4
Oct 22, 2026Miller MarySale513US$1.84Form 4
Oct 5, 2026Miller MarySale294US$1.99Form 4
Aug 25, 2026Blume-Jensen PeterSale14,036US$2.21Form 4
Aug 18, 2026Masson KristinaSale1,229US$2.01Form 4

Acrivon Therapeutics, Inc. shareholders